Importantly, Treg induction is less pronounced than with regular IL-2, and a direct comparison of Neo2/15 with equimolar recombinant IL-2 showed greater anti-tumour activity of the synthetic cytokine [31]. The gene discussed is IL2; the disease is neoplasm.